84 related articles for article (PubMed ID: 2855293)
21. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
23. A comparative study of endralazine and captopril in essential hypertension: effect on renin levels, pulmonary function studies and lipid profile.
Hauger-Klevene JH; Reader C; Mayer E; Sanchez MR
Int J Clin Pharmacol Res; 1986; 6(4):275-81. PubMed ID: 3531038
[TBL] [Abstract][Full Text] [Related]
24. [Mechanisms of the hypotensive action of captopril in essential hypertension].
Ustinova SE; Zhukova IM; Uchitel' IA; Parfenova EV; Chernova NA
Kardiologiia; 1986 Dec; 26(12):72-6. PubMed ID: 3031355
[TBL] [Abstract][Full Text] [Related]
25. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
Hashimoto H; Hiwada K; Kokubu T
Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
[TBL] [Abstract][Full Text] [Related]
26. [Plasma leucine enkephalin and beta-endorphin levels in patients with essential hypertension and the effects of captopril].
Gao Y
Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):327-9, 24. PubMed ID: 2169983
[TBL] [Abstract][Full Text] [Related]
27. [The efficacy of the captopril treatment of elderly hypertension patients].
Korkushko OV; Fedirko MI; Gidzinskaia IN
Vrach Delo; 1990 Feb; (2):10-3. PubMed ID: 2187303
[TBL] [Abstract][Full Text] [Related]
28. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486
[TBL] [Abstract][Full Text] [Related]
29. [Effect of long-term treatment with guanfacine on selected humoral metabolic indices in patients with primary hypertension].
Knypl K; Wocial B; Chodakowska J; Brym E; Czerniewska E; Wacławek-Maczkowska J; Kuczyńska K; Berent H; Januszewicz W
Pol Tyg Lek; 1989 Mar 20-27; 44(12-13):293-6. PubMed ID: 2530502
[TBL] [Abstract][Full Text] [Related]
30. Comparison of once-daily captopril or enalapril in mild essential hypertension.
Pixley JS; Marshall MK; Stanley H; Starich GH; Ferguson RK
J Clin Pharmacol; 1989 Feb; 29(2):118-22. PubMed ID: 2541177
[TBL] [Abstract][Full Text] [Related]
31. Dilation of forearm blood vessels after angiotensin-converting-enzyme inhibition by captopril in hypertensive patients.
Johns DW; Ayers CR; Williams SC
Hypertension; 1984; 6(4):545-50. PubMed ID: 6086518
[TBL] [Abstract][Full Text] [Related]
32. Renin-angiotensin system and opioids during acute hemorrhage in conscious rabbits.
Schadt JC; Gaddis RR
Am J Physiol; 1990 Feb; 258(2 Pt 2):R543-51. PubMed ID: 2155547
[TBL] [Abstract][Full Text] [Related]
33. Comparison of sublingual and oral captopril in hypertension.
Dessì-Fulgheri P; Bandiera F; Rubattu S; Cocco F; Madeddu P; Oppes M; Tonolo GC; Glorioso N; Rappelli A
Clin Exp Hypertens A; 1987; 9(2-3):593-7. PubMed ID: 3038422
[TBL] [Abstract][Full Text] [Related]
34. Influence of food on acute and chronic effects of captopril in essential hypertensive patients.
Salvetti A; Pedrinelli R; Magagna A; Abdel-Haq B; Graziadei L; Taddei S; Stornello M
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S25-9. PubMed ID: 2580172
[TBL] [Abstract][Full Text] [Related]
35. [Gonadectomy-induced reduction of antihypertensive action of angiotensin converting enzyme inhibitor and its role of central renin activity in spontaneously hypertensive rats].
Kumai T
Nihon Naibunpi Gakkai Zasshi; 1991 Nov; 67(11):1231-9. PubMed ID: 1662161
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy.
Niarchos AP; Resnick LM; Weinstein DL; Laragh JH
Am J Med; 1985 Oct; 79(4):435-44. PubMed ID: 2864856
[TBL] [Abstract][Full Text] [Related]
37. [Effect of a single dose of intravenous captopril in hypertensive subjects].
Franchi M; Puccetti F; Landini F; Burresi A; Di Perri T
Recenti Prog Med; 1988 Jun; 79(6):261-6. PubMed ID: 2843976
[No Abstract] [Full Text] [Related]
38. The influence of naloxone on the circulatory effects of captopril.
Rubin PC; Millar JA; Sturani S; Lawrie C; Reid JL
Br J Clin Pharmacol; 1984 Jun; 17(6):713-7. PubMed ID: 6331480
[TBL] [Abstract][Full Text] [Related]
39. [Use of captopril (capoten) in arterial hypertension].
Erina EV; Zhukova IM; Ustinova SE; D'iakonova EG; Masenko VP
Kardiologiia; 1985 Jun; 25(6):19-24. PubMed ID: 3900522
[TBL] [Abstract][Full Text] [Related]
40. Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients.
Bernini GP; Lucarini AR; Vivaldi MS; Del Corso C; Lenzi M; Salvetti A
Cardiovasc Drugs Ther; 1989 Dec; 3(6):829-33. PubMed ID: 2487544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
